A company owned by Goldman Sachs is at the forefront of a lobbying campaign by fertilizer manufacturers associated with “forever chemicals.” The chemicals in question are known as per- and polyfluoroalkyl substances (PFAS), which have been connected to numerous health and environmental concerns.
This lobbying effort, spearheaded by Altamont Technologies and other industry players, is aimed at influencing regulations and policies regarding the use of PFAS in fertilizers. While the makers argue that PFAS-containing fertilizers are essential for crop productivity, critics raise concerns about the potential health risks posed by these chemicals.
Goldman Sachs, through its control of Altamont Technologies, is receiving backlash for its involvement in promoting PFAS-containing fertilizers. Environmental activists and public health advocates are calling for stricter regulations on PFAS usage and expressing alarm over the potential negative impacts on human health and the environment.
The issue of PFAS contamination has gained increased scrutiny in recent years, with growing evidence of the chemicals’ persistence in the environment and their possible links to health problems such as cancer, infertility, and developmental delays. As a result, calls for tighter regulations on PFAS have been growing louder.
The connection between Goldman Sachs, Altamont Technologies, and the lobbying efforts of fertilizer makers highlights the complex intersection of financial interests and public health concerns. As the debate over PFAS-containing fertilizers continues to intensify, it remains to be seen how regulatory authorities will respond to these issues and what implications they may have for the agricultural industry and the broader environment.
Source
Photo credit www.nytimes.com